← FDA Drug Approvals (Drugs@FDA)
IZERVAY
NDA · New Drug Application · Sponsor: ASTELLAS · Approved 2023-08-04
Drug application
- FDA Application #
NDA217225
- Application type
- New Drug Application
- Brand name
- IZERVAY
- Generic name
- AVACINCAPTAD PEGOL
- Active ingredients
- AVACINCAPTAD PEGOL SODIUM
- Dosage form
- SOLUTION
- Route
- INTRAVITREAL
- Marketing status
- Prescription
- Sponsor
- ASTELLAS
- Manufacturer
- Astellas Pharma US, Inc.
- First approval
- 2023-08-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown